Delivery Order SPE2DB20D3103-SPE2DB22FM0K2
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, with a ceiling value of $7,758.39, is for the delivery of COPAXONE 20 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 10, 2023 and is structured as a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,241.53 firm fixed-price delivery order is for the supply of COPAXONE 40 MG/ML syringes, with a period of performance through January 31, 2024. The award is not associated with a specific set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award is for the delivery of COPAXONE 40 MG/ML syringes to the Medical Supply Chain, a unit of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $8,925.37. The contract is a Firm Fixed Price Delivery Order with a completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,905.61 Firm Fixed Price Delivery Order is for the supply of COPAXONE 20 MG/ML SYRINGE ML, a specialty medication. The award has an ultimate completion date of May 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $1,839.36 for the supply of COPAXONE 40 MG/ML SYRINGEML, a medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of November 12, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,387.55 delivery order contract is for the supply of Copaxone 20 mg/mL syringes, a specialty medication. The contract has a completion date of December 19, 2022 and is a firm fixed-price delivery order. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,583.28 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564466149 COPAXONE 40 MG/ML SYRINGEML and has a performance period through May 2, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award, valued at $4,562.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order for the supply of 4563596016 - COPAXONE 20 MG/ML SYRINGE/ML, with a completion date of February 9, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award, valued at $1,448.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COPAXONE 40 MG/ML SYRINGEML, a pharmaceutical product, with a performance period ending on March 12, 2025. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of COPAXONE 40 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order has a potential value of $2,269.52 and a completion date of February 28, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is not designated as a...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM0K2Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) to provide COPAXONE 40 MG/ML SYRINGEML, a specialty pharmaceutical product. The $24,288.34 firm-fixed-price delivery order has a completion date of December 21, 2021 and was awarded on December 20, 2021. The contract was awarded through full and open competition, without any set-aside designation. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 12/20/21 |